
Innoviva, Inc.: A US-based healthcare asset management firm, specializing in bio-pharmaceutical development and finance.
Innoviva, Inc., founded in Burlingame, United States, is a healthcare-focused asset management company dedicated to the development, commercialization, and financial management of biopharmaceuticals. The company's core mission is to advance innovative therapies that improve patient outcomes while maximizing shareholder value. Innoviva primarily operates within the United States, targeting the biopharmaceutical sector with a focus on strategic investments and partnerships to drive growth and innovation.
Notable figures associated with Innoviva include key executives and board members with extensive experience in the healthcare and financial sectors. The company has secured significant investments from prominent venture capital firms and institutional investors. Innoviva's key achievements include successful collaborations with leading biopharmaceutical companies, resulting in the development and commercialization of several high-impact therapies. The overall impact of Innoviva has been substantial in advancing medical treatments and contributing to the financial success of its stakeholders.

BiotechInnova
biotechinnova.com

Innovu
innovu.com

INVO Fertility
invobioscience.com
Aliva Biopharmaceuticals

Camino Innovation Holdings
Commerce Health Ventures

Enavate Sciences

INNOVATE
innovatecorp.com

Hepanova
hepanova.com

Invenra
invenra.com

Novita Therapeutics

Innovo Therapeutics

Inova Strategic Investments

Complexa
Companies similar to Innoviva include BiotechInnova, Innovu, INVO Fertility and Aliva Biopharmaceuticals.
Innoviva was founded in 1996.
Innoviva's headquarters is located in Brisbane, CA, US.
Innoviva's most recent funding round was for $225M (USD) in March 2022.
As of Mar 3, 2022, Innoviva has raised a total of $225M (USD).
Innoviva has 101 employees as of Feb 6, 2024.